Read + Share
Fu S, Corr BR, Culm-Merdek K, Mockbee C, et al. Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With
Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer. J Clin Oncol 2022;40:2568-2577.
PMID: 35439029
|
 |
|
Fu S, Corr BR, Culm-Merdek K, Mockbee C, et al. Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With
Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer. J Clin Oncol 2022;40:2568-2577.
PMID: 35439029
|
|
|
|